These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 21683128

  • 21. Development of dry salbutamol sulfate powder with high inhalation performance independent of inhalation patterns.
    Hira D, Okuda T, Ichihashi M, Kojima H, Okamoto H.
    Chem Pharm Bull (Tokyo); 2012; 60(3):334-40. PubMed ID: 22382413
    [Abstract] [Full Text] [Related]

  • 22. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
    Kaialy W, Nokhodchi A.
    Int J Pharm; 2013 May 01; 448(1):58-70. PubMed ID: 23500603
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M, Shekunov BY, York P, Lechuga-Ballesteros D, Miller DP, Tan T, Colthorpe P.
    Eur J Pharm Sci; 2004 May 01; 22(1):1-17. PubMed ID: 15113578
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J, Lähde A, Kauppinen EI.
    Int J Pharm; 2009 Jan 05; 365(1-2):18-25. PubMed ID: 18789380
    [Abstract] [Full Text] [Related]

  • 27. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D, Young PM, Jones M, Edge S, Price R.
    Eur J Pharm Sci; 2006 Feb 05; 27(2-3):243-51. PubMed ID: 16330191
    [Abstract] [Full Text] [Related]

  • 28. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H, Markefka P, teWierik H, Kammelar R.
    Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The crystal engineering of salbutamol sulphate via simulated pulmonary surfactant monolayers.
    Davies MJ, Kerry TD, Seton L, Murphy MF, Gibbons P, Khoo J, Naderi M.
    Int J Pharm; 2013 Mar 25; 446(1-2):34-45. PubMed ID: 23391511
    [Abstract] [Full Text] [Related]

  • 34. Influence of mechanical activation on the physical stability of salbutamol sulphate.
    Brodka-Pfeiffer K, Langguth P, Grass P, Häusler H.
    Eur J Pharm Biopharm; 2003 Nov 25; 56(3):393-400. PubMed ID: 14602182
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    J Pharm Pharmacol; 2000 Oct 25; 52(10):1211-21. PubMed ID: 11092565
    [Abstract] [Full Text] [Related]

  • 40. The influence of carrier and drug morphology on drug delivery from dry powder formulations.
    Larhrib H, Martin GP, Marriott C, Prime D.
    Int J Pharm; 2003 May 12; 257(1-2):283-96. PubMed ID: 12711183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.